These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 31991053

  • 1. Late-onset hypogonadism and lifestyle-related metabolic disorders.
    Braga PC, Pereira SC, Ribeiro JC, Sousa M, Monteiro MP, Oliveira PF, Alves MG.
    Andrology; 2020 Nov; 8(6):1530-1538. PubMed ID: 31991053
    [Abstract] [Full Text] [Related]

  • 2. Late-onset hypogonadism: metabolic impact.
    Grossmann M, Ng Tang Fui M, Cheung AS.
    Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
    [Abstract] [Full Text] [Related]

  • 3. Assessment and management of male androgen disorders: an update.
    Chan I, Fui MN, Zajac JD, Grossmann M.
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [Abstract] [Full Text] [Related]

  • 4. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
    Maggi M, Filippi S, Vignozzi L, Rastrelli G.
    Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
    [Abstract] [Full Text] [Related]

  • 5. Influence of the hypothalamic-pituitary-adrenal axis dysregulation on the metabolic profile of patients affected by diabetes mellitus-associated late onset hypogonadism.
    Tirabassi G, Chelli FM, Ciommi M, Lenzi A, Balercia G.
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):53-9. PubMed ID: 26643209
    [Abstract] [Full Text] [Related]

  • 6. DYSREGULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INCREASES CENTRAL BODY FAT ACCUMULATION IN MALES AFFECTED BY DIABETES MELLITUS AND LATE-ONSET HYPOGONADISM.
    Tirabassi G, Muscogiuri G, Colao A, Balercia G.
    Endocr Pract; 2016 Apr; 22(4):427-33. PubMed ID: 26684153
    [Abstract] [Full Text] [Related]

  • 7. Late-onset hypogonadism: a concept comes of age.
    Nieschlag E.
    Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
    [Abstract] [Full Text] [Related]

  • 8. [Risk of Male Infertility Due to Testosterone Replacement Therapy for Late-Onset Hypogonadism (LOH)].
    Sukegawa G, Tsuji Y.
    Hinyokika Kiyo; 2020 Nov; 66(11):407-409. PubMed ID: 33271659
    [Abstract] [Full Text] [Related]

  • 9. Late-onset Hypogonadism: Bone health.
    Rochira V.
    Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.
    Corona G, Rastrelli G, Maggi M.
    Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):557-79. PubMed ID: 24054931
    [Abstract] [Full Text] [Related]

  • 11. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C, Ceausu I, Depypere H, Lambrinoudaki I, Mueck A, Pérez-López FR, Rees M, van der Schouw YT, Senturk LM, Simonsini T, Stevenson JC, Stute P, Goulis DG.
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological management of late-onset hypogonadism.
    Rastrelli G, Maggi M, Corona G.
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):439-458. PubMed ID: 29505313
    [Abstract] [Full Text] [Related]

  • 13. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
    Amano T, Imao T, Takemae K, Iwamoto T, Nakanome M.
    Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
    [Abstract] [Full Text] [Related]

  • 14. Opioids and the Hypothalamic-Pituitary-Gonadal (HPG) Axis.
    Wehbeh L, Dobs AS.
    J Clin Endocrinol Metab; 2020 Sep 01; 105(9):. PubMed ID: 32770254
    [Abstract] [Full Text] [Related]

  • 15. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM.
    Adv Exp Med Biol; 2017 Sep 01; 1043():473-526. PubMed ID: 29224108
    [Abstract] [Full Text] [Related]

  • 16. Androgen-dependent miR-125a-5p targets LYPLA1 and regulates global protein palmitoylation level in late-onset hypogonadism males.
    Qu M, Zhao Y, Qing X, Zhang X, Li H.
    J Cell Physiol; 2021 Jun 01; 236(6):4738-4749. PubMed ID: 33284463
    [Abstract] [Full Text] [Related]

  • 17. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T.
    Clin Calcium; 2013 Aug 01; 23(8):1179-84. PubMed ID: 23892219
    [Abstract] [Full Text] [Related]

  • 18. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment.
    Huhtaniemi I.
    Asian J Androl; 2014 Aug 01; 16(2):192-202. PubMed ID: 24407185
    [Abstract] [Full Text] [Related]

  • 19. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH, Kim JJ.
    Asian J Androl; 2011 Jul 01; 13(4):563-8. PubMed ID: 21572448
    [Abstract] [Full Text] [Related]

  • 20. Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden?
    Corona G, Maseroli E, Rastrelli G, Francomano D, Aversa A, Hackett GI, Ferri S, Sforza A, Maggi M.
    Minerva Endocrinol; 2016 Jun 01; 41(2):196-210. PubMed ID: 26883937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.